SMTL ID : 6c1s.1

Phosphoinositide 3-Kinase gamma bound to an pyrrolopyridinone Inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

monomer

Ligands

1 x EFV: {4-[2-(5,6-dimethoxypyridin-3-yl)-5-oxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1H-pyrazol-1-yl}acetonitrile(Non-covalent)

EFV.1: 17 residues within 4Å: Chain A: P.671, W.673, I.692, K.694, D.697, L.699, D.702, Y.728, I.740, E.741, I.742, V.743, K.744, A.746, M.814, I.824, D.825 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.824, A:I.824 Hydrogen bonds: A:K.694, A:D.697, A:Y.728, A:V.743, A:D.825 Water bridges: A:D.702 pi-Stacking: A:W.673, A:Y.728

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: P.67, L.68, W.73, K.149 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:L.68, A:L.68 Salt bridges: A:K.149 SO4.3: 6 residues within 4Å: Chain A: D.807, R.808, H.809, N.812, I.829, W.947 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:H.809, A:N.812 Salt bridges: A:R.808 SO4.4: 3 residues within 4Å: Chain A: W.437, R.440, K.467 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:W.437 Salt bridges: A:R.440, A:K.467 SO4.5: 4 residues within 4Å: Chain A: L.518, F.555, F.559, Q.707 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Q.707, A:Q.707 Water bridges: A:R.710 Salt bridges: A:R.710

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Come, J.H. et al., Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase gamma (PI3K gamma ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS). J. Med. Chem. (2018)

Release Date

2018-06-27

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence